UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The natural history and outcomes of vaginal sarcoma — A Surveillance, Epidemiology, and End Results database analysis

Gynecologic oncology, 2015-02, Vol.136 (2), p.409-409

Growdon, W.B

2015

Volltextzugriff (PDF)

Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva

Gynecologic oncology, 2012-10, Vol.127 (1), p.141-146

2012

Volltextzugriff (PDF)

Racial disparities in incidence and survival of gynecologic sarcoma: An analysis of 19,797 women within the Surveillance, Epidemiology, and End Results database

Gynecologic oncology, 2016-06, Vol.141, p.52-53

2016

Volltextzugriff (PDF)

Elevated body mass index (BMI) is associated with a decreased risk of recurrence and increased administration of adjuvant radiation and chemotherapy

Gynecologic oncology, 2017-06, Vol.145, p.148-148

2017

Volltextzugriff (PDF)

Comparing survival of vulvar melanoma and squamous cell carcinoma: An analysis of 13,112 patients in the Surveillance, Epidemiology and End Results database

Gynecologic oncology, 2015-04, Vol.137, p.170-170

2015

Volltextzugriff (PDF)

Comparing vaginal sarcoma and carcinoma in the Surveillance, Epidemiology and End Results program, 1988 to 2010: An analysis of 4062 patients

Gynecologic oncology, 2015-04, Vol.137, p.99-99

2015

Volltextzugriff (PDF)

Comparing the natural history and survival of vulvar sarcoma and squamous cell carcinoma: An analysis 11,677 cases in the Surveillance, Epidemiology, and End Results database

Gynecologic oncology, 2015-04, Vol.137, p.164-164

2015

Volltextzugriff (PDF)

The use of neoadjuvant chemotherapy in advanced endometrial cancer

Gynecologic oncology reports, 2021-05, Vol.36, p.100725-100725, Article 100725

2021

Volltextzugriff (PDF)

Targeting HER2 and PI3K in Uterine Serous Cancer

Gynecologic oncology, 2015-12, Vol.139 (3), p.596-596

2015

Volltextzugriff (PDF)

Next-generation genomic signature highlights sustained AKT and estrogen receptor signaling as key mediators of resistance following phosphatidylinositol 3-kinase (PI3K) inhibition in patient-derived xenograft models with and without PIK3CA gene mutations

Gynecologic oncology, 2016-06, Vol.141, p.147-147

2016

Volltextzugriff (PDF)

Timing of referral to the New England Trophoblastic Disease Center: Does referral with molar pregnancy versus postmolar gestational trophoblastic neoplasia affect outcomes?

Gynecologic oncology, 2016-06, Vol.141, p.148-148

2016

Volltextzugriff (PDF)

Adjuvant hysterectomy for cervical cancer: Indications, complications, and outcomes

Gynecologic oncology, 2016-06, Vol.141, p.143-143

2016

Volltextzugriff (PDF)

Outcomes among women diagnosed with cervical cancer at the time of hysterectomy

Gynecologic oncology, 2016-06, Vol.141, p.183-183

2016

Volltextzugriff (PDF)

Minimally invasive radical hysterectomy for cervical cancer reduces morbidity with similar outcomes compared with laparotomy

Gynecologic oncology, 2016-06, Vol.141, p.188-188

2016

Volltextzugriff (PDF)

Laparoscopic interval debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer

Gynecologic oncology, 2017-06, Vol.145, p.125-125

2017

Volltextzugriff (PDF)

Fertility-conserving surgery among young women with stage I epithelial ovarian cancer: Analysis of the National Cancer Data Base

Gynecologic oncology, 2017-06, Vol.145, p.39-40

2017

Volltextzugriff (PDF)

Characterization of immune regulatory molecules B7-H4 and PD-L1 in low- and high-grade endometrial tumors

Gynecologic oncology, 2017-06, Vol.145, p.90-90

2017

Volltextzugriff (PDF)

Aborted upfront debulking does not reduce likelihood of optimal interval debulking compared with planned neoadjvuant chemotherapy

Gynecologic oncology, 2017-06, Vol.145, p.125-126

2017

Volltextzugriff (PDF)

Management of type II/high-grade endometrial cancer: A prospective cohort study utilizing a standard algorithm

Gynecologic oncology, 2016-06, Vol.141, p.88-88

2016

Volltextzugriff (PDF)

Racial disparities in survival in malignant germ cell tumors of the ovary

Gynecologic oncology, 2016-06, Vol.141, p.89-89

2016

Volltextzugriff (PDF)

Outcomes among patients with advanced-stage low-grade serous ovarian cancer: Analysis of the National Cancer Data Base, 2003-2011

Gynecologic oncology, 2016-06, Vol.141, p.55-55

2016

Volltextzugriff (PDF)

PI3K coupled to PARP inhibition demonstrates synergistic anti-tumor activity in endometrioid endometrial cancer patient derived xenografts

Gynecologic oncology, 2015-04, Vol.137, p.65-65

2015

Volltextzugriff (PDF)

A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer

Gynecologic oncology, 2016-04, Vol.141 (1), p.108-112

2016

Volltextzugriff (PDF)

Participation in ovarian cancer clinical trials is associated with improved overall survival

Gynecologic oncology, 2019-06, Vol.154, p.214-215

2019

Volltextzugriff (PDF)

Dose delay, but not dose reduction, in chemotherapy administration is associated with decreased survival in elderly women with ovarian cancer

Gynecologic oncology, 2014-06, Vol.133, p.32-32

2014

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(74)

Sprache

Englisch
(74)

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(41)
Obstetrics And Gynecology
(41)
Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Obstetrics & Gynecology
(8)
Oncology
(8)
Female
(7)
Humans
(7)
Aged
(5)
Middle Aged
(5)
Aged, 80 And Over
(3)
Adult
(2)
Chemotherapy
(2)
Endometrial Cancer
(2)
Ovarian Cancer
(2)
Ovarian Neoplasms - Genetics
(2)
Readmission
(2)
Rehabilitation Facility
(2)
Squamous Cell Carcinoma
(2)
Vulvar Cancer
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gynecologic Oncology
(70)
Gynecologic Oncology Reports
(1)
International Journal Of Gynecological Cancer
(1)
Neurology
(1)
Oncogene
(1)

Menü

Weitere Dienste

Einstellungen

The natural history and outcomes of vaginal sarcoma — A Surveillance, Epidemiology, and End Results database analysis

Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva

Racial disparities in incidence and survival of gynecologic sarcoma: An analysis of 19,797 women within the Surveillance, Epidemiology, and End Results database

Elevated body mass index (BMI) is associated with a decreased risk of recurrence and increased administration of adjuvant radiation and chemotherapy

Comparing survival of vulvar melanoma and squamous cell carcinoma: An analysis of 13,112 patients in the Surveillance, Epidemiology and End Results database

Comparing vaginal sarcoma and carcinoma in the Surveillance, Epidemiology and End Results program, 1988 to 2010: An analysis of 4062 patients

Comparing the natural history and survival of vulvar sarcoma and squamous cell carcinoma: An analysis 11,677 cases in the Surveillance, Epidemiology, and End Results database

The use of neoadjuvant chemotherapy in advanced endometrial cancer

Targeting HER2 and PI3K in Uterine Serous Cancer

Next-generation genomic signature highlights sustained AKT and estrogen receptor signaling as key mediators of resistance following phosphatidylinositol 3-kinase (PI3K) inhibition in patient-derived xenograft models with and without PIK3CA gene mutations

Timing of referral to the New England Trophoblastic Disease Center: Does referral with molar pregnancy versus postmolar gestational trophoblastic neoplasia affect outcomes?

Adjuvant hysterectomy for cervical cancer: Indications, complications, and outcomes

Outcomes among women diagnosed with cervical cancer at the time of hysterectomy

Minimally invasive radical hysterectomy for cervical cancer reduces morbidity with similar outcomes compared with laparotomy

Laparoscopic interval debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer

Fertility-conserving surgery among young women with stage I epithelial ovarian cancer: Analysis of the National Cancer Data Base

Characterization of immune regulatory molecules B7-H4 and PD-L1 in low- and high-grade endometrial tumors

Aborted upfront debulking does not reduce likelihood of optimal interval debulking compared with planned neoadjvuant chemotherapy

Management of type II/high-grade endometrial cancer: A prospective cohort study utilizing a standard algorithm

Racial disparities in survival in malignant germ cell tumors of the ovary

Outcomes among patients with advanced-stage low-grade serous ovarian cancer: Analysis of the National Cancer Data Base, 2003-2011

PI3K coupled to PARP inhibition demonstrates synergistic anti-tumor activity in endometrioid endometrial cancer patient derived xenografts

A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer

Participation in ovarian cancer clinical trials is associated with improved overall survival

Dose delay, but not dose reduction, in chemotherapy administration is associated with decreased survival in elderly women with ovarian cancer

Suchergebnisse filtern